TIDMAMS
RNS Number : 0863N
Advanced Medical Solutions Grp PLC
03 May 2018
3 May 2018
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the surgical and advanced wound care specialist company, announces
that the Trust which manages the Deferred Share Bonus Plan ("Plan")
on behalf of the employees of AMS has purchased ordinary shares of
5 pence each ("Ordinary Shares") on 30 April 2018, at a price of
306.77p on behalf of Chris Meredith, Mary Tavener, Simon Coates,
Rose Guang, Eddie Johnson, Becky Walmsley, Jeff Willis, Pieter van
Hoof and Cathy Tomlinson ("PDMRs") as part of the Deferred Share
Bonus Plan and, under the terms of the Plan, these shares will be
held in trust on their behalf.
Following these transactions the beneficial ownership of the
PDMRs is as follows:
Director/PDMR Date purchased Shares Resultant % of issued
purchased holding share capital
================== ================ =========== ========== ===============
Chris Meredith
Chief Executive 30 April
Officer 2018 2,316 1,484,395 0.697%
================== ================ =========== ========== ===============
Mary Tavener
Chief Financial 30 April
Officer 2018 586 1,960,277 0.920%
================== ================ =========== ========== ===============
Simon Coates 30 April
PDMR 2018 3,754 97,581 0.046%
================== ================ =========== ========== ===============
Rose Guang 30 April
PDMR 2018 6,670 42,729 0.020%
================== ================ =========== ========== ===============
Eddie Johnson 30 April
PDMR 2018 6,845 55,579 0.026%
================== ================ =========== ========== ===============
Becky Walmsley 30 April
PDMR 2018 2,419 5,888 0.003%
================== ================ =========== ========== ===============
Jeff Willis 30 April
PDMR 2018 4,057 165,396 0.078%
================== ================ =========== ========== ===============
Pieter van
Hoof 30 April
PDMR 2018 3,867 127,208 0.060%
================== ================ =========== ========== ===============
Cathy Tomlinson 30 April
PDMR 2018 4,458 4,458 0.002%
================== ================ =========== ========== ===============
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Chris Meredith
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: Director/PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 2,316 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------
a) Name: Mary Tavener
--- ---------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------
a) Position/status: Director/PDMR
--- ---------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------
b) Nature of the transactions:
* Purchase of 586 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- ---------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- ---------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- ---------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- ---------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Simon Coates
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 3,754 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Rose Guang
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 6,670 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Eddie Johnson
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 6,845 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Becky Walmsley
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 2,419 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Jeff Willis
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 4,057 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Pieter van Hoof
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 3,867 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Cathy Tomlinson
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 4,458 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
- End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Financial
Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Matthew Neal AMS@consilium-comms.com
/ Philippa Gardner
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb /
Gary Clarence
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands; ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 75 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 600 employees. For
more information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFIREAIVIIT
(END) Dow Jones Newswires
May 03, 2018 12:12 ET (16:12 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024